Connection

C. Chou to Antineoplastic Agents

This is a "connection" page, showing publications C. Chou has written about Antineoplastic Agents.
Connection Strength

0.330
  1. Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor. J Med Chem. 2015 May 28; 58(10):4325-38.
    View in: PubMed
    Score: 0.073
  2. Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity. J Med Chem. 2014 Apr 24; 57(8):3324-41.
    View in: PubMed
    Score: 0.068
  3. Histone deacetylase inhibitors with enhanced enzymatic inhibition effects and potent in vitro and in vivo antitumor activities. ChemMedChem. 2014 Mar; 9(3):638-48.
    View in: PubMed
    Score: 0.066
  4. Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity. Chem Biol Drug Des. 2013 Aug; 82(2):125-30.
    View in: PubMed
    Score: 0.064
  5. A novel class of small molecule inhibitors of HDAC6. ACS Chem Biol. 2012 Feb 17; 7(2):331-9.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.